Stay updated on Pegcetacoplan in C3 Glomerulopathy: Clinical Trial

Sign up to get notified when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No changes were detected (no additions or deletions provided).
    Difference
    0.0%
    Check dated 2026-04-23T15:21:11.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T11:15:41.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The study location entry now shows Padova, Italy 35128 instead of Padua, Italy 35128. This aligns the listing with the local city name.
    Difference
    0.0%
    Check dated 2026-04-09T08:38:24.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Mesangiocapillary glomerulonephritis, type II to the study's condition terms.
    Difference
    0.0%
    Check dated 2026-04-02T05:00:16.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added Complement 3 glomerulopathy to the study’s conditions list and removed Non-immunoglobulin-mediated membranoproliferative glomerulonephritis from the list.
    Difference
    0.0%
    Check dated 2026-03-25T22:45:25.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T19:42:58.000Z thumbnail image

Stay in the know with updates to Pegcetacoplan in C3 Glomerulopathy: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.